Clinical Trial Update: Protein Tyrosine Kinases (PTK) in Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial updating the use of protein tyrosine kinase inhibitors in multiple myeloma has completed enrollment and status as reported by ClinicalT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED